Brief: Genome & Company Announces Positive Topline Results From Phase 2 Clinical Trial Of Combination Of Gen-001 And Bavencio® For The Treatment Of Gastric Cancer Poster Presented At Asco Gi24/01/2024 15:43
Brief: Positive Results From Interim Analysis Of 'GEN-001' Plus Avelumab Phase II Trial19/05/2023 14:45
Last trade - 00:00Last trade - 00:00Last trade - 00:00